Five Companies To Watch At The Jefferies Conference
Europe’s Biggest Investor Meeting
Novartis and Roche will present alongside up-and-coming biotechs and microcaps.
You may also be interested in...
Why Pfizer, Vertex and Biogen executives green-lighted investments in technologies to check seal integrity, ingredient dryness and other process attributes.
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
One of a new wave of treatments, Novartis has focused on proving its drug cuts vaso-occlusive crises (VOCs), or pain crises.